nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A double-blind, randomised, placebo-controlled, phase 2b study evaluating sorafenib in combination with paclitaxel as a first-line therapy in patients with HER2-negative advanced breast cancer
|
Gradishar, William J. |
|
2013 |
49 |
2 |
p. 312-322 11 p. |
artikel |
2 |
A first in human phase I study of the proteasome inhibitor CEP-18770 in patients with advanced solid tumours and multiple myeloma
|
Gallerani, Elisa |
|
2013 |
49 |
2 |
p. 290-296 7 p. |
artikel |
3 |
An European Organisation for Research and Treatment of Cancer phase I study of lapatinib and docetaxel as neoadjuvant treatment for Human Epidermal Growth Factor Receptor 2 (HER2) positive locally-advanced/inflammatory or large operable breast cancer
|
Bonnefoi, H. |
|
2013 |
49 |
2 |
p. 281-289 9 p. |
artikel |
4 |
A single mutation in Securin induces chromosomal instability and enhances cell invasion
|
Mora-Santos, Mar |
|
2013 |
49 |
2 |
p. 500-510 11 p. |
artikel |
5 |
Association analysis between breast cancer genetic variants and mammographic density in a large population-based study (Determinants of Density in Mammographies in Spain) identifies susceptibility loci in TOX3 gene
|
Fernandez-Navarro, Pablo |
|
2013 |
49 |
2 |
p. 474-481 8 p. |
artikel |
6 |
Bcl-2 associated anthanogen-1 (Bag-1) expression and prognostic value in pancreatic head and periampullary cancer
|
van der Zee, Jill A. |
|
2013 |
49 |
2 |
p. 323-328 6 p. |
artikel |
7 |
Childhood cancer: Incidence and early deaths in Argentina, 2000–2008
|
Moreno, Florencia |
|
2013 |
49 |
2 |
p. 465-473 9 p. |
artikel |
8 |
Clinicopathological differences between breast cancer in patients with primary metastatic disease and those without: A multicentre study
|
Barinoff, J. |
|
2013 |
49 |
2 |
p. 305-311 7 p. |
artikel |
9 |
Combined interaction of multi-locus genetic polymorphisms in cytarabine arabinoside metabolic pathway on clinical outcomes in adult acute myeloid leukaemia (AML) patients
|
Kim, Kyung Im |
|
2013 |
49 |
2 |
p. 403-410 8 p. |
artikel |
10 |
Denosumab for treatment of bone metastases secondary to solid tumours: Systematic review and network meta-analysis
|
Ford, John A. |
|
2013 |
49 |
2 |
p. 416-430 15 p. |
artikel |
11 |
Dissociated responses to newer antimyeloma drugs identify a subset of refractory patients with an extremely poor prognosis
|
Crickx, Etienne |
|
2013 |
49 |
2 |
p. 411-415 5 p. |
artikel |
12 |
Evaluation of sexuality, health-related quality-of-life and depression in advanced cancer patients: A prospective study in a Phase I clinical trial unit of predominantly targeted anticancer drugs
|
Rouanne, Mathieu |
|
2013 |
49 |
2 |
p. 431-438 8 p. |
artikel |
13 |
Feasibility and benefits of second-line chemotherapy in advanced biliary tract cancer: A large retrospective study
|
Walter, Thomas |
|
2013 |
49 |
2 |
p. 329-335 7 p. |
artikel |
14 |
18F-labelled fluorodeoxyglucose–positron emission tomography (FDG–PET) heterogeneity of response is prognostic in dabrafenib treated BRAF mutant metastatic melanoma
|
Carlino, Matteo S. |
|
2013 |
49 |
2 |
p. 395-402 8 p. |
artikel |
15 |
Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck
|
Keil, Felix |
|
2013 |
49 |
2 |
p. 352-359 8 p. |
artikel |
16 |
Influence of semi-quantitative oestrogen receptor expression on adjuvant endocrine therapy efficacy in ductal and lobular breast cancer – A TEAM study analysis
|
van de Water, Willemien |
|
2013 |
49 |
2 |
p. 297-304 8 p. |
artikel |
17 |
Localised angiosarcomas: The identification of prognostic factors and analysis of treatment impact. A retrospective analysis from the French Sarcoma Group (GSF/GETO)
|
Lindet, Clothilde |
|
2013 |
49 |
2 |
p. 369-376 8 p. |
artikel |
18 |
Magnetic resonance spectroscopy metabolite profiles predict survival in paediatric brain tumours
|
Wilson, Martin |
|
2013 |
49 |
2 |
p. 457-464 8 p. |
artikel |
19 |
MTA1-mediated transcriptional repression of SMAD7 in breast cancer cell lines
|
Salot, Shimul |
|
2013 |
49 |
2 |
p. 492-499 8 p. |
artikel |
20 |
Panobinostat activity in both bexarotene-exposed and -naïve patients with refractory cutaneous T-cell lymphoma: Results of a phase II trial
|
Duvic, Madeleine |
|
2013 |
49 |
2 |
p. 386-394 9 p. |
artikel |
21 |
Prognostic factors in adolescents and young adults (AYA) with high risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: A study based on pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62771 and 62931
|
Kasper, Bernd |
|
2013 |
49 |
2 |
p. 449-456 8 p. |
artikel |
22 |
Quality of life analysis in patients with KRAS wild-type metastatic colorectal cancer treated first-line with cetuximab plus irinotecan, fluorouracil and leucovorin
|
Láng, István |
|
2013 |
49 |
2 |
p. 439-448 10 p. |
artikel |
23 |
Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer
|
Marchini, Sergio |
|
2013 |
49 |
2 |
p. 520-530 11 p. |
artikel |
24 |
Retinoic acid-induced protein 3: Identification and characterisation of a novel prognostic colon cancer biomarker
|
Zougman, Alexandre |
|
2013 |
49 |
2 |
p. 531-539 9 p. |
artikel |
25 |
Risk of de novo cancers after transplantation: Results from a cohort of 7217 kidney transplant recipients, Italy 1997–2009
|
Piselli, Pierluca |
|
2013 |
49 |
2 |
p. 336-344 9 p. |
artikel |
26 |
The kinase RSK2 modulates the sensitivity of ovarian cancer cells to cisplatin
|
van Jaarsveld, Marijn T.M. |
|
2013 |
49 |
2 |
p. 345-351 7 p. |
artikel |
27 |
The neuropeptide 26RFa is expressed in human prostate cancer and stimulates the neuroendocrine differentiation and the migration of androgeno-independent prostate cancer cells
|
Alonzeau, Jessy |
|
2013 |
49 |
2 |
p. 511-519 9 p. |
artikel |
28 |
The stimulation of A3 adenosine receptors reduces bone-residing breast cancer in a rat preclinical model
|
Varani, Katia |
|
2013 |
49 |
2 |
p. 482-491 10 p. |
artikel |
29 |
The T genotype of the MGMT C>T (rs16906252) enhancer single-nucleotide polymorphism (SNP) is associated with promoter methylation and longer survival in glioblastoma patients
|
McDonald, K.L. |
|
2013 |
49 |
2 |
p. 360-368 9 p. |
artikel |
30 |
The value of C-reactive protein and comorbidity in predicting survival of patients with high grade soft tissue sarcoma
|
Nakamura, Tomoki |
|
2013 |
49 |
2 |
p. 377-385 9 p. |
artikel |